TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT00778206

Intervention type: DRUG
Intervention: Kuvan
Description: -Recommended post-partum Assessments include: collection of baby's plasma at Birth, 1 Month and 6 months, and collection of mother's plasma and expressed breast milk sample at 1 Month.
Study: NCT04903938

Intervention type: BEHAVIORAL
Intervention: Primary And Secondary Abilities Among The Individuals With Antisocial Personality Disorder Within The Scope Of Positive Psychotherapy: Their Relationship With Criminal Behaviors, Aggression And Anger
Description: Participants will be given scales with validity and reliability studies in Turkish.

Intervention type: BEHAVIORAL
Intervention: Primary And Secondary Abilities Among The Individuals With Antisocial Personality Disorder Within The Scope Of Positive Psychotherapy: Their Relationship With Criminal Behaviors, Aggression And Anger
Description: Participants will be given scales with validity and reliability studies in Turkish.

Intervention type: BEHAVIORAL
Intervention: Primary And Secondary Abilities Among The Individuals With Antisocial Personality Disorder Within The Scope Of Positive Psychotherapy: Their Relationship With Criminal Behaviors, Aggression And Anger
Description: Participants will be given scales with validity and reliability studies in Turkish.
Study: NCT01132027

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tacrolimus Capsules
Description: Tacrolimus Capsules, 5 mg of Dr. Reddy's Laboratories Limited

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tacrolimus Capsules
Description: Tacrolimus Capsules, 5 mg of Dr. Reddy's Laboratories Limited
Study: NCT03801863

Intervention type: PROCEDURE
Intervention: Ultrasound-guided Erector Spinae Plane Block with Ropivacaine 0.375%
Description: Ultrasound-guided Erector Spinae Plane Block will be done at L4 interspace. Ropivacaine 0.375% will be used.

Intervention type: DRUG
Intervention: Ropivacaine
Description: Using 0.375% Ropivacaine in the nerve block
Study: NCT00960648

Intervention type: DEVICE
Intervention: Xience/Promus
Description: Active prospective registration of patients receiving everolimus-eluting stent

Intervention type: DEVICE
Intervention: Cypher
Description: Retrospective historical controls that received sirolimus-eluting stent
Study: NCT01315626

Intervention type: OTHER
Intervention: Primary Care Educational event
Description: The purpose of this study is to assess the accuracy of primary care physicians in diagnosing BE and evaluate the impact of an educational intervention targeting those primary care physicians and providing instruction in the recognition and treatment of BE. The hope is that a better understanding of the disease will result in more accurate diagnoses and ultimately in more appropriate care for these patients. In addition to better care for patients, earlier recognition of bronchiectasis may result in a decrease in health care costs.

Intervention type: OTHER
Intervention: Primary Care Educational event
Description: The purpose of this study is to assess the accuracy of primary care physicians in diagnosing BE and evaluate the impact of an educational intervention targeting those primary care physicians and providing instruction in the recognition and treatment of BE. The hope is that a better understanding of the disease will result in more accurate diagnoses and ultimately in more appropriate care for these patients. In addition to better care for patients, earlier recognition of bronchiectasis may result in a decrease in health care costs.
Study: NCT00564473

Intervention type: BEHAVIORAL
Intervention: questionnaire
Description: * questionnaire of demographic and medical data, use of and attituded toward herbal medicine.~* Beck Depression Inventory-Second Edition (BDI-II)- Hebrew Translation
Study: NCT01969331

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Normia
Description: One capsule twice a day/14 days

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: maltodextrin, microcrystalline cellulose; hypromellose, silicium dioxide (E551), magnesium stearate, colouring agent: titanium dioxide ( E171)
Study: NCT03446846

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MIN-117 5.0 mg
Description: 5.0 mg MIN-117 administered as two MIN-117 2.5 mg capsules as a single dose once daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MIN-117 2.5 mg
Description: 2.5 mg MIN-117 administered as one MIN-117 2.5 mg capsule and one Placebo capsule as a single dose once daily

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo administered as two Placebo capsules as a single dose once daily
Study: NCT03379038

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Progressive Physical Therapy
Description: Stretching of the tight muscle, positioning, abdominal co activation; rolling etc to decrease muscle tone and functional independence.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Maintenance Physical Therapy
Description: Same Physical therapy protocol but aim was to maintain current level of spasticity and functioning
Study: NCT02059681

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Autologous bone marrow derived-CD133+ cells
Description: Cell therapy
Study: NCT02719093

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: recombinant FSH
Description: Subcutaneous injection
Study: NCT00501969

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rotigotine
Description: Rotigotine trans-dermal patches once daily:~20 cm2 (4 mg/24 hours); 30 cm2 (6 mg/24 hours); 40 cm2 (8 mg/24 hours) 50 cm2 (10 mg/24 hours) 60 cm2 (12 mg/24 hours) 70 cm2 (14 mg/24 hours) 80 cm2 (16 mg/24 hours)
Study: NCT02191033

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Smoking counseling

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Smoking counseling

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Text messaging
Study: NCT04095338

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: virtual reality games intervention
Description: Each session will include 30 minutes of traditional physical rehabilitation therapy followed by 20 minutes of robotic training by Tymo system (Tyromotion, Austria), a wireless platform for the balance and the postural control training that simulates floor walking and stairs climbing. Tymo system is connected to a screen and provides virtual reality games, adaptable to the functional capacity of the patient. Through the games proposed, the physiotherapist will decide to work in a dimension (antero-posterior or medio-lateral dimension) or in two dimensions (combining the antero-posterior and medio-lateral movements).

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: robotic treadmill intervention
Description: Each session will include 30 minutes of traditional physical rehabilitation therapy followed by 20 minutes of robotic training by Walker view (TecnoBody, Italy), a treadmill equipped with a sensorized belt with eight load cells and a 3D camera.to detect length, speed and symmetry of the pace and load, range of the trunk, hips and knees. Patients will be asked to walk at a comfortable speed, while the physiotherapist will be able to work on different parameters such as step length, load distribution, and step height. The setting will take place taking into account the clinical conditions of each patient, customizing the intervention. The Walker View will offer visual and auditory feedback to the patient, so as to correct gait in real time.
Study: NCT01927484

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 25 mg/week oral methotrexate tablets
Description: active oral methotrexate drug

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: 25mg/week oral placebo tablets
Description: placebo comparator oral drug
Study: NCT03169855

Intervention type: DIAGNOSTIC_TEST
Intervention: Slit lamp (LOCS III Score)
Description: Diagnostic procedure only
Study: NCT04285645

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Warmup
Description: The intervention through exercises will consist in the application of the protocol described by Waldén et al. The objective of the application of this exercise protocol is to produce an improvement in the stability of the knee and the strength of the quadriceps. Before carrying out the exercises, a continuous race will be carried out for 5 minutes, once this first step is finished we will proceed to the realization of the exercises that will be, squats with both legs placing the hands on the hips, feet placed at the width of the shoulders, lowering with a straight back and without raising the heels of the floor, 3 series of 15 repetitions, squats on one leg with the hands on the hips and leg not supported extended forward, 3 sets of 10 repetitions with each leg and jump forward with one leg with the hands on the hips and jump back to return to the starting position, 3 sets of 10 repetitions with each leg
Study: NCT02191033

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nicotine patch

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nicotine patch
Study: NCT01574976

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: probabilistic choice
Description: subjects should choose between low-certain outcome and high-uncertain outcome

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: probabilistic choice
Description: subjects should choose between low-certain outcome and high-uncertain outcome

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: probabilistic choice
Description: subjects should choose between low-certain outcome and high-uncertain outcome

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: probabilistic choice
Description: subjects should choose between low-certain outcome and high-uncertain outcome
Study: NCT04085562

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bisoprolol Fumarate 5-10 mg
Description: Bisoprolol as antihypertensive drug in patients on hemodialysis

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Amlodipine 5-10 mg
Description: Amlodipine as antihypertensive drug in patients on hemodialysis
Study: NCT04333316

Intervention type: PROCEDURE
Group type: OTHER
Intervention: dual mobility cup
Description: implantation of dual mobility total hip
Study: NCT02737241

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Low power Holmium laser enucleation of the prostate
Description: HoLEP entails dissection of the whole median and lateral prostatic lobes off the surgical capsule via a retrograde approach starting at the apex. The enucleated lobes were pushed to the bladder followed by hemostasis of the prostate bed then intravesical morcellation of the enucleated adenoma. The procedure entails power setting of 50W holmium laser energy.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: High power Holmium laser enucleation of the prostate
Description: HoLEP entails dissection of the whole median and lateral prostatic lobes off the surgical capsule via a retrograde approach starting at the apex. The enucleated lobes were pushed to the bladder followed by hemostasis of the prostate bed then intravesical morcellation of the enucleated adenoma. The procedure entails power setting of 100W holmium laser energy.
Study: NCT03707210

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: VR training program
Description: Use VR software to make a training education program.
Study: NCT03131791

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Shock Wave
Description: 42 chronic stroke patients with upper limb spasticity were randomly assigned to receive either 1 session of ESWT per week for 3 consecutive weeks or BoNT-A injection. The biceps, flexor carpi radialis, and flexor carpi ulnaris muscles were treated. Assessments were performed at baseline and at 1, 4, and 8 weeks after the intervention. The primary outcome measure was the change in the Modified Ashworth Scale (MAS) score for the elbow from the baseline to after 4 weeks of treatment.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Botulinum toxin A
Description: 42 chronic stroke patients with upper limb spasticity were randomly assigned to receive either 1 session of ESWT per week for 3 consecutive weeks or BoNT-A injection. The biceps, flexor carpi radialis, and flexor carpi ulnaris muscles were treated. Assessments were performed at baseline and at 1, 4, and 8 weeks after the intervention. The primary outcome measure was the change in the Modified Ashworth Scale (MAS) score for the elbow from the baseline to after 4 weeks of treatment.
Study: NCT02057549

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Haloperidol
Description: Intravenous dose of haloperidol 5 mg.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Therapy
Description: Conventional Therapy includes hydration via IV fluids, pain control with analgesics (usually opiates) frequently requiring multiple doses, also antiemetics (often requires multiple doses and different agents in attempts to control nausea and vomiting within this population), in addition to electrolytes abnormalities corrections as needed.
Study: NCT01738347

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Arm 1 - GEH120714 (18F) Injection
Description: Intervention is to administer GEH120714 (18F) Injection (100-270 Megabecquerel (MBq), single intravenous administration).
Study: NCT03165812

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: SADJB-SG group
Description: Patients will undergo bariatric surgery. A clear liquid high protein diet will be started in the first two postoperative days. If no complications were detected by physical examination, patients will be stimulated to walk and will be dismissed from the hospital on postoperative day 3. Patients will be subjected to a strict adherence to diet and close monitoring of their blood glucose and HbA1c levels during the study period. Standard follow-up includes a visit to the outpatient clinic at 1, 2, 3, 4 weeks after surgery, then 3, 6, 9, 12, 18, 24 months and after that, a life-long annual visit. Glycaemic control at home will be maintained as in the preoperative period and patients will need to inform the results of their blood glucose levels to the doctor during each follow-up visits.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: IMT group
Description: Patients will be subjected to strict adherence to their diet, optimisation of their diabetic medications and close monitoring of their blood glucose and HbA1c levels at 0, 6, 12, 24 months. The endocrinologist will be monitoring the patients in this group. Detailed individualized lifestyle and dietary counseling will be given by a dietitian emphasizing on nutrition knowledge, the timing of meal with medication, portion control, and increasing daily physical activity level.
Study: NCT01277783

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Endocardial Left Ventricular pacing
Description: Subjects receive an endocardial LV lead placement via superior approach using Medtronic Model 3830 lead and Medtronic Model 6227ATS deflectable delivery catheter and Medtronic Model 6248HS, 6248JL, or 6248JS delivery catheter, using trans esophageal echo (TEE) or intra-cardiac echo (ICE) to guide the procedure.
Study: NCT02174627

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Roxadustat
Description: The initial study drug dose is 70 mg three times a week (TIW). The dose is subsequently adjusted to achieve and maintain Hb 11±1 g/dL.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: The initial study drug dose is 70 mg three times a week (TIW). The dose is subsequently adjusted to achieve and maintain Hb 11±1 g/dL.
Study: NCT00107627

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Caprosyn subcuticular sutures.
Description: Caprosyn subcuticular sutures.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Monocryl subcuticular sutures.
Description: Monocryl subcuticular sutures.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Skin staples;
Description: Skin staples;
Study: NCT02271633

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Beetroot juice

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Beetroot juice

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Spinach

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Spinach

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Spinach

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Rocket salad

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Rocket salad

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Rocket salad
Study: NCT01354496

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY2409021 Reference Form
Description: Administered orally

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY2409021 Test-Med Formulation (medium particle size)
Description: Administered orally

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY2409021 Test-Med Formulation (medium particle size)
Description: Administered orally

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY2409021 Test-Med Formulation (medium particle size)
Description: Administered orally

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY2409021 Test-High Formulation (high particle size)
Description: Administered orally

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY2409021 Test-Low Formulation (low particle size)
Description: Administered orally
Study: NCT03978975

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Food intake
Description: For all those session, subjects will take a standardized breakfast (570kcal) three hours before experimental session.~Control session (CON): subject will stand sited without any activity during 40 min.~Subjects will be submitted to three aquatic cycling exercise session:~* session 27°C :aquatic cycling at 27°C without water jet during 40 min~* session 27°C+ water jets : aquatic cycling at 27 °C with water jets during 40 min~* session 18°C : aquatic cycling at 187°C without water jet during 40 min Every exercise session will be set at 70% of theorical maximal heart rate During each session, oxygen consumption and carbon dioxide production will be analysed with gas analysis system. Appetite and hunger sensation will be measured with a specific scale at different time point of each day of experimental session. Thirty minutes after the end of each experimental session subjects will have a buffet meal for lunch time.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Food intake
Description: For all those session, subjects will take a standardized breakfast (570kcal) three hours before experimental session.~Control session (CON): subject will stand sited without any activity during 40 min.~Subjects will be submitted to three aquatic cycling exercise session:~* session 27°C :aquatic cycling at 27°C without water jet during 40 min~* session 27°C+ water jets : aquatic cycling at 27 °C with water jets during 40 min~* session 18°C : aquatic cycling at 187°C without water jet during 40 min Every exercise session will be set at 70% of theorical maximal heart rate During each session, oxygen consumption and carbon dioxide production will be analysed with gas analysis system. Appetite and hunger sensation will be measured with a specific scale at different time point of each day of experimental session. Thirty minutes after the end of each experimental session subjects will have a buffet meal for lunch time.
Study: NCT01159964

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Immunotherapeutic GSK2302032A, different formulations
Description: Intramuscular administration

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Immunotherapeutic GSK2302032A, different formulations
Description: Intramuscular administration

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Immunotherapeutic GSK2302032A, different formulations
Description: Intramuscular administration
Study: NCT02869373

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: spinal stabilizaton exercise
Description: In Exercise group, spinal stabilization exercise program was carried out 3 days a week for 8 weeks.
Study: NCT01448070

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: human insulin
Description: Single dose of 0.2 IU/kg, administered subcutaneously (under the skin)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: human insulin
Description: Single dose of 0.2 IU/kg, administered subcutaneously (under the skin)
Study: NCT04025697

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Complete Denture
Description: A conventional CD will be constructed

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Rapid prototyped denture
Description: A 3d printed complete denture will be constructed
Study: NCT04060901

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CCSH Intervention for Teams
Description: CCSH Interventions for Teams will be a six session intervention. The groups meet once per week for 60 minutes for 4 weeks, coupled with 2 booster sessions over the following 2 months. Participants will receive the CCSH interventional approach, adapted for a group setting, which follows four stages: 1) Preparing the care responder; 2) Attuning to the Relationship; 3) Accessing Compassion, and 4) Entrusting the Careseeker.~The CCSH approach will be used to assess group dynamics, individual member sources of distress, as well as existing resources for resilience and compassion. Through the intervention, resources will then be identified and accessed in order to respond to team (and individual) sources of distress with greater resilience and increased compassion toward self and others. CCSH clinicians will utilize group process skills to encourage team communication about work-related challenges, enhance team cohesion, and enable interpersonal support among members of the team.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CCSH Intervention for Teams
Description: CCSH Interventions for Teams will be a six session intervention. The groups meet once per week for 60 minutes for 4 weeks, coupled with 2 booster sessions over the following 2 months. Participants will receive the CCSH interventional approach, adapted for a group setting, which follows four stages: 1) Preparing the care responder; 2) Attuning to the Relationship; 3) Accessing Compassion, and 4) Entrusting the Careseeker.~The CCSH approach will be used to assess group dynamics, individual member sources of distress, as well as existing resources for resilience and compassion. Through the intervention, resources will then be identified and accessed in order to respond to team (and individual) sources of distress with greater resilience and increased compassion toward self and others. CCSH clinicians will utilize group process skills to encourage team communication about work-related challenges, enhance team cohesion, and enable interpersonal support among members of the team.
Study: NCT01081431

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lenalidomide
Description: 10 mg d1-d21 of a 28-day cycle
Study: NCT00942110

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CPAP treatment
Description: maintains upper airway patency and minimizes the obstructive events